Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

81.47
Delayed Data
As of Aug 23
 +0.55 / +0.68%
Today’s Change
77.92
Today|||52-Week Range
113.31
-19.49%
Year-to-Date
Gilead (GILD) Truvada Gets EU Approval for Label Expansion
Aug 23 / Zacks.com - Paid Partner Content
ETFs in Focus on Pfizer's Medivation Acquisition
Aug 22 / Zacks.com - Paid Partner Content
Galapagos (GLPG) Advances RA Drug Filgotinib to Phase III
Aug 23 / Zacks.com - Paid Partner Content
Biotechs Continue to Lead a Listless Market
Aug 22 / TheStreet.com - Paid Partner Content
3 Cheap Healthcare Stocks Paying Dividends Now
Aug 23 / MotleyFool.com - Paid Partner Content
10 Low PE Stock Picks for the Enterprising Investor - August
Aug 22 / GuruFocus News - Paid Partner Content
Advanced Micro Devices and the Three Year Gamble
Aug 22 / GuruFocus News - Paid Partner Content
Pfizer nears $14bn takeover of Medivation
Aug 21 / FT.com - Paid Partner Content
Here's Why a Gilead Stock Split Is Unlikely
Aug 22 / MotleyFool.com - Paid Partner Content
3 Reasons Medivation Is the Juiciest Target in Biotech
Aug 21 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close80.92
Today’s open81.46
Day’s range81.02 - 81.64
Volume8,279,443
Average volume (3 months)10,180,229
Market cap$106.8B
Dividend yield2.31%
Data as of 08/23/2016

Growth & Valuation

Earnings growth (last year)+62.04%
Earnings growth (this year)-6.60%
Earnings growth (next 5 years)-1.30%
Revenue growth (last year)+28.71%
P/E ratio7.2
Price/Sales4.80
Price/Book6.21

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen+0.05+0.03%
BIIBBiogen+1.36+0.43%
BAXBaxter International...0.000.00%
ILMNIllumina Inc-0.96-0.55%
Data as of 08/23/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$2.88
Annual revenue (last year)$32.0B
Annual profit (last year)$18.1B
Net profit margin56.52%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts

Partner Offers

Search for Jobs